Perazella Mark A, Rosner Mitchell H
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.
Veteran's Affairs Medical Center, West Haven, Connecticut.
Clin J Am Soc Nephrol. 2022 Aug;17(8):1220-1233. doi: 10.2215/CJN.11290821. Epub 2022 Mar 10.
Medications are a common cause of AKI, especially for patients admitted to hospital wards and the intensive care unit. Although drug-related kidney injury occurs through different mechanisms, this review will focus on three specific types of tubulointerstitial injury. Direct acute tubular injury develops from several medications, which are toxic to various cellular functions. Their excretory pathways through the proximal tubules contribute further to AKI. Drug-induced AKI may also develop through induction of inflammation within the tubulointerstitium. Medications can elicit a T cell-mediated immune response that promotes the development of acute interstitial nephritis leading to AKI. Although less common, a third pathway to kidney injury results from the insolubility of drugs in the urine leading to their precipitation as crystals within distal tubular lumens, causing a crystalline-related AKI. Intratubular obstruction, direct tubular injury, and localized inflammation lead to AKI. Clinicians should be familiar with the pathogenesis and clinical-pathologic manifestations of these forms of kidney injury. Prevention and treatment of AKI relies on understanding the pathogenesis and judiciously using these agents in settings where AKI risk is high.
药物是急性肾损伤(AKI)的常见病因,尤其是对于入住医院病房和重症监护病房的患者。尽管药物相关性肾损伤通过不同机制发生,但本综述将聚焦于三种特定类型的肾小管间质损伤。直接急性肾小管损伤由多种对各种细胞功能有毒性的药物引起。它们通过近端小管的排泄途径进一步加重急性肾损伤。药物性急性肾损伤也可能通过诱导肾小管间质内的炎症而发生。药物可引发T细胞介导的免疫反应,促进急性间质性肾炎的发展,进而导致急性肾损伤。虽然不太常见,但导致肾损伤的第三条途径是药物在尿液中不溶,导致其在远端肾小管腔内沉淀为晶体,从而引起与结晶相关的急性肾损伤。肾小管内梗阻、直接肾小管损伤和局部炎症导致急性肾损伤。临床医生应熟悉这些形式的肾损伤的发病机制和临床病理表现。急性肾损伤的预防和治疗依赖于了解发病机制,并在急性肾损伤风险高的情况下谨慎使用这些药物。